These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
691 related articles for article (PubMed ID: 16677860)
1. Is a new tuberculosis vaccine necessary and feasible? A Cuban opinion. Sierra VG Tuberculosis (Edinb); 2006; 86(3-4):169-78. PubMed ID: 16677860 [TBL] [Abstract][Full Text] [Related]
2. [Novel vaccines against M. tuberculosis]. Okada M Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920 [TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
6. Prospects for elimination of childhood tuberculosis: the role of new vaccines. Hatherill M Arch Dis Child; 2011 Sep; 96(9):851-6. PubMed ID: 21450742 [TBL] [Abstract][Full Text] [Related]
7. Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development. Dietrich J; Doherty TM APMIS; 2009 May; 117(5-6):440-57. PubMed ID: 19400867 [TBL] [Abstract][Full Text] [Related]
9. Vaccine approaches to prevent tuberculosis. Wiker HG; Mustafa T; Målen H; Riise AM Scand J Immunol; 2006 Sep; 64(3):243-50. PubMed ID: 16918693 [TBL] [Abstract][Full Text] [Related]
10. Tuberculosis vaccine. Sarhan MA Saudi Med J; 2010 Jan; 31(1):9-13. PubMed ID: 20062891 [TBL] [Abstract][Full Text] [Related]
11. Is intranasal vaccination a feasible solution for tuberculosis? Giri PK; Khuller GK Expert Rev Vaccines; 2008 Nov; 7(9):1341-56. PubMed ID: 18980538 [TBL] [Abstract][Full Text] [Related]
12. Childhood tuberculosis: old and new vaccines. Hussey G; Hawkridge T; Hanekom W Paediatr Respir Rev; 2007 Jun; 8(2):148-54. PubMed ID: 17574159 [TBL] [Abstract][Full Text] [Related]
13. Optimal models to evaluate the protective efficacy of tuberculosis vaccines. Griffin JF; Chinn DN; Rodgers CR; Mackintosh CG Tuberculosis (Edinb); 2001; 81(1-2):133-9. PubMed ID: 11463234 [TBL] [Abstract][Full Text] [Related]
14. Vaccine researchers rise to the challenge of resurgent TB. Vaccine Immun News; 1996 Jun; (1):4-6. PubMed ID: 12179918 [TBL] [Abstract][Full Text] [Related]
15. Tuberculosis vaccination versus isoniazid preventive therapy: a decision analysis to determine the preferred strategy of tuberculosis prevention in HIV-infected adults in the developing world. Sterling TR; Brehm WT; Moore RD; Chaisson RE Int J Tuberc Lung Dis; 1999 Mar; 3(3):248-54. PubMed ID: 10094327 [TBL] [Abstract][Full Text] [Related]
16. The second Geneva Consensus: Recommendations for novel live TB vaccines. Walker KB; Brennan MJ; Ho MM; Eskola J; Thiry G; Sadoff J; Dobbelaer R; Grode L; Liu MA; Fruth U; Lambert PH Vaccine; 2010 Mar; 28(11):2259-70. PubMed ID: 20074686 [TBL] [Abstract][Full Text] [Related]
17. Vaccination strategies to prevent tuberculosis in the new millennium: from BCG to new vaccine candidates. Franco-Paredes C; Rouphael N; del Rio C; Santos-Preciado JI Int J Infect Dis; 2006 Mar; 10(2):93-102. PubMed ID: 16377228 [TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and protective efficacy of a DNA vaccine encoding the fusion protein of mycobacterium heat shock protein 65 (Hsp65) with human interleukin-2 against Mycobacterium tuberculosis in BALB/c mice. Wang LM; Bai YL; Shi CH; Gao H; Xue Y; Jiang H; Xu ZK APMIS; 2008 Dec; 116(12):1071-81. PubMed ID: 19133010 [TBL] [Abstract][Full Text] [Related]
19. Tuberculosis vaccines: past, present and future. Martin C Curr Opin Pulm Med; 2006 May; 12(3):186-91. PubMed ID: 16582673 [TBL] [Abstract][Full Text] [Related]
20. Tuberculosis: looking beyond BCG vaccines. Mustafa Abu S; Al-Attiyah R J Postgrad Med; 2003; 49(2):134-40. PubMed ID: 12867689 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]